Article
Screening for genetic mutations in patients with neuropathy without definite etiology is useful.
Journal of neurology - 1 Sept 2020
Vogt Braden, Chahin Nizar, Wiszniewski Wojciech, Ragole Thomas, Karam Chafic
Abstract excerpt
OBJECTIVE: To determine the clinical usefulness of systemic genetic testing in neuropathies without definite etiology. METHODS: We systematically performed genetic testing in all patients with neuropathy who did not have a definite etiology, seen at our neuromuscular clinic between 2017 and 2020. The testing consisted of an inherited neuropathy panel (72-81 genes), which used next-generation sequencing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
